1 |
Tenover, F. C.; Biddle, J. W.; Lancaster, M. V. Emerg. Infect. Dis. 2001, 7, 327-32.
DOI
|
2 |
Tiwari, H. K.; Sen, M. R. BMC Infect. Dis. 2006, 6, 156.
DOI
|
3 |
Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb. Mortal. Wkly. Rep. 2002, 51, 565.
|
4 |
Smith, S. M.; Eng, R. H. Antimicrob. Agents Chemother. 1989, 33, 181-4.
DOI
ScienceOn
|
5 |
Westblom, T. U.; Abele, B. Am. J. Med. 1988, 85, 884.
DOI
|
6 |
Hansch, C.; Leo, A. American Chemical Society 1995, p 557.
|
7 |
Kubinyi.; H. Ed.; VCH: New York, 1993, p 240.
|
8 |
Bonde, C. G.; Gaikwad, N. J. bioorg. Med. Chem. 2004(12), p 2151-2561.
|
9 |
Chierakul, W.; Rajanuwong, A.; Chaowagul, W.; White, N. J. ‘Antimicrobial drugs use and therapeutics’, Trans. Royal Soc. Trop. Med. Hig 2004, 98, 678.
DOI
|
10 |
Hiramatsu, K. Am. J. Med. 1998, 104, 7S-10S.
DOI
|
11 |
Hiramatsu, K.; Hanaki, H.; Ino, T.; Tenoverm F. C. J. Antimicrob. Chemother. 1997, 40, 135-6.
DOI
|
12 |
Sieradzki, K.; Roberts, R. B.; Haber, S. W. N. Engl. J. Med. 1999, 340, 517-23.
DOI
|
13 |
Smith, T. L.; Pearson, M. L.; Wilcox, K. R. N. Engl. J. Med. 1999, 340, 493-501.
DOI
|
14 |
Barreca, M. L.; Rao, A.; S. Ferro, G. J. Chem. Inf. Model. 47 (2007) 557e562.
DOI
|
15 |
National Committee for Clinical Laboratory Standards, 6th ed., 2003, M7-A6 (ISBN 1-56238-486-4).
|
16 |
Eckert, R.; Qi, F. Antimicrob. Agents Chemother. 2006, 50, 1480-8.
DOI
|
17 |
Masunari, A.; Rezende, P.; Tavares, L. C. Abstracts of Papers, CADD & D Society in Turkey: Istanbul, 2004; p 63.
|
18 |
Ranetto, M.; Santos, M. Braz. J. Pharm. Sci., 2001; Suppl. 1, p 62.
|
19 |
Ha, K. R.; Psaltis, A. J.; Butcher, A. R. Laryngoscope 2008, 118, 535-40.
DOI
|
20 |
O’Gara, J. P. FEMS Microbiol. Lett. 2007, 270, 179-88.
DOI
|